Kay P, Ahmad A, Floten S, Starr A
Br Heart J. 1985 Mar;53(3):260-4. doi: 10.1136/hrt.53.3.260.
Sixteen patients underwent emergency coronary artery bypass surgery immediately after intracoronary streptokinase infusion for acute evolving myocardial infarction. Of these, 11 patients had 70% residual stenosis in the recanalised vessel, and in five thrombolysis was unsuccessful. There were no hospital deaths. All the patients sustained myocardial necrosis, the peak activity of creatine phosphokinase correlating with the time to reperfusion. Chest tube drainage (mean 960 ml) was significantly higher than for control patients but did not correlate with the total dosage of streptokinase. No patients had further myocardial infarction or developed recurrent angina. Selected patients may benefit from coronary bypass surgery after intracoronary streptokinase infusion. If necessary this may be performed immediately with low mortality and morbidity.
16例急性进展性心肌梗死患者在冠状动脉内输注链激酶后立即接受了急诊冠状动脉搭桥手术。其中,11例患者再通血管存在70%的残余狭窄,5例溶栓未成功。住院期间无死亡病例。所有患者均发生心肌坏死,肌酸磷酸激酶的峰值活性与再灌注时间相关。胸管引流量(平均960 ml)显著高于对照组患者,但与链激酶总剂量无关。无患者发生进一步心肌梗死或复发性心绞痛。部分患者在冠状动脉内输注链激酶后可能从冠状动脉搭桥手术中获益。如有必要,可立即进行该手术,死亡率和发病率较低。